La Merie

La Merie is a provider of information about biopharmaceutical R&D and competitive intelligence by Publishing, Consultancy and its Biotech Portal PipelineReview.com. La Merie produces, edits and publishes La Merie Daily, R&D Pipeline News, Competitor Analysis reports and full reports.

Results 61 - 79 of 79 go to 1st page

first

previous 1 2 3 4 next

Title	Date	Price
Integrin Antagonists Competitor Analysis	Jun 2008	£225
Antihypertensives Competitor Analysis	Jun 2008	£270
Heat shock protein 90 (Hsp90) Inhibitors Competitor Analysis	May 2008	£110
Adenosine Receptor Agonists & Antagonists Competitor Analysis	May 2008	£110
NGF Agonists and Antagonists Competitor Analysis	May 2008	£89
CD40 and CD40L (CD154) Agonists and Antagonists Brief Report	Apr 2008	£225
Anti-Obesity Biologics Competitor Analysis	Mar 2008	£89
Interleukin-12 (IL-12) and IL-23 Antagonists Brief Report	Feb 2008	£135
Syk Kinase Inhibitors Brief Report	Feb 2008	£135
Interleukin-13 (IL-13) Antibodies Brief Report	Feb 2008	£270
Systemic Lupus Erythematosus (SLE) Competitor Analysis	Feb 2008	£180
GM-CSF Antibodies Brief Report	Jan 2008	£180
Death Receptors TRAIL-R1/2 Brief Report	Jan 2008	£180
Blockbuster Drugs 2006: Executive Overview	Aug 2007
R&D Pipeline News - Therapeutic Area Edition: 1-Year Subscription Periodical	Jan 1970
R&D Pipeline News - Technology Edition: 1-Month Subscription Periodical	Jan 1970
R&D Pipeline News - Therapeutic Area Edition: 1-Month Subscription Periodical	Jan 1970
R&D Pipeline News - Technology Edition: 1-Year Subscription Periodical	Jan 1970